Complications posttransplantation (N = 44)
| Complication . | Value . |
|---|---|
| Engraftment syndrome, n (%) | 16 (36) |
| Acute GVHD, n (% of GVHD) | 21 (48) |
| Grade I | 9 (43) |
| Skin only | 9 (43) |
| Grade II | 7 (33) |
| Skin only | 6 (29) |
| Skin + gastrointestinal | 1 (5) |
| Grade III | 5 (24) |
| Skin + gastrointestinal | 2 (10) |
| Gastrointestinal only | 3 (14) |
| Grade IV | 0 (0) |
| GVHD grade I-IV onset, median (range), d | 47 (13-145) |
| GVHD grade II-IV onset, median (range), d | 39.5 (14-145) |
| Whole-blood chimerism (donor percentage) at 1 y (n = 37), n (%) | |
| >95% | 28 (76) |
| 90-95% | 2 (5) |
| 75-89% | 5 (14) |
| 50-74% | 1 (3) |
| 25-49% | 1 (3) |
| <25% | 0 (0) |
| T-cell chimerism (donor percentage) at 1 y (n = 35), n (%) | |
| >95% | 22 (63) |
| 90%-95% | 5 (14) |
| 75%-89% | 4 (11) |
| 50%-74% | 3 (9) |
| 25%-49% | 1 (3) |
| <25% | 0 (0) |
| Opportunistic infections at 1 y, n (% of infections) | 27 (61) |
| Adenovirus | 11 (41) |
| EBV | 10 (37) |
| HHV-6 | 9 (33) |
| CMV | 6 (22) |
| Mycobacteria | 1 (4) |
| Fungal | 1 (4) |
| Complication . | Value . |
|---|---|
| Engraftment syndrome, n (%) | 16 (36) |
| Acute GVHD, n (% of GVHD) | 21 (48) |
| Grade I | 9 (43) |
| Skin only | 9 (43) |
| Grade II | 7 (33) |
| Skin only | 6 (29) |
| Skin + gastrointestinal | 1 (5) |
| Grade III | 5 (24) |
| Skin + gastrointestinal | 2 (10) |
| Gastrointestinal only | 3 (14) |
| Grade IV | 0 (0) |
| GVHD grade I-IV onset, median (range), d | 47 (13-145) |
| GVHD grade II-IV onset, median (range), d | 39.5 (14-145) |
| Whole-blood chimerism (donor percentage) at 1 y (n = 37), n (%) | |
| >95% | 28 (76) |
| 90-95% | 2 (5) |
| 75-89% | 5 (14) |
| 50-74% | 1 (3) |
| 25-49% | 1 (3) |
| <25% | 0 (0) |
| T-cell chimerism (donor percentage) at 1 y (n = 35), n (%) | |
| >95% | 22 (63) |
| 90%-95% | 5 (14) |
| 75%-89% | 4 (11) |
| 50%-74% | 3 (9) |
| 25%-49% | 1 (3) |
| <25% | 0 (0) |
| Opportunistic infections at 1 y, n (% of infections) | 27 (61) |
| Adenovirus | 11 (41) |
| EBV | 10 (37) |
| HHV-6 | 9 (33) |
| CMV | 6 (22) |
| Mycobacteria | 1 (4) |
| Fungal | 1 (4) |
EBV, Epstein-Barr virus; HHV, human herpesvirus 6.